Showing results (201-210 of 425) with videos related to

Sort By:
Pageof 43
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2005
Select high-risk genetic features predict earlier progression following chemoimmunotherapy with fludarabine and rituximab in chronic lymphocytic leukemia: justification for risk-adapted therapyJohn C Byrd, John G Gribben, Bercedis L Peterson, et al.
British Journal of Haematology|February 3, 2009
The humanized CD40 antibody SGN-40 demonstrates pre-clinical activity that is enhanced by lenalidomide in chronic lymphocytic leukaemiaRosa Lapalombella, Aruna Gowda, Trupti Joshi, et al.
Plos One|June 23, 2011
LyGDI, a novel SHIP-interacting protein, is a negative regulator of FcγR-mediated phagocytosisPayal Mehta, Anne-Sophie Wavreille, Steven E Justiniano, et al.
Blood Advances|July 12, 2018
Ten-year outcome of patients with acute myeloid leukemia not treated with allogeneic transplantation in first complete remissionSumithira Vasu, Jessica Kohlschmidt, Krzysztof Mrózek, et al.
Genes, Chromosomes & Cancer|January 13, 2005
Acute myeloid leukemia with deletion 9q within a noncomplex karyotype is associated with CEBPA loss-of-function mutationsStefan Fröhling, Richard F Schlenk, Jürgen Krauter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 9, 2021
Biologic Assignment Trial of Reduced-Intensity Hematopoietic Cell Transplantation Based on Donor Availability in Patients 50-75 Years of Age With Advanced Myelodysplastic SyndromeRyotaro Nakamura, Wael Saber, Michael J Martens, et al.
Lancet (London, England)|February 21, 2004
Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemiaAdolfo A Ferrando, Donna S Neuberg, Richard K Dodge, et al.
Pageof 43